ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Association of monocyte-to-lymphocyte ratio, neutrophil-to-lymphocyte ratio, and tumor necrosis factor-α in various stages of chronic kidney disease

Desty Indah Sari, Puspa Wardhani, Yessy Puspitasari, Satriyo Dwi Suryantoro.



Abstract
Download PDF Post

Chronic inflammation can have a considerable impact on the progression of glomerular and tubulointerstitial pathologies in chronic kidney disease (CKD). As an alternative to the early detection of inflammatory markers that are most important in the progression of CKD, this study aims to analyze the association of MLR, NLR, and TNF-? with the stages of CKD. This cross-sectional study conducted at Universitas Airlangga Hospital, Surabaya, Indonesia, in mid-2023 involved 65 CKD subjects, consisting of 5 stages of CKD according to KDIGO guidelines. eGFR was calculated using the CKD-EPI creatinine equation. MLR and NLR were calculated from the differential count hematology analyzer Sysmex XN-550. TNF-α was examined using the sandwich ELISA method. Random-spot urine was used for the UACR examination (TMS 24i Premium Chemical Analyzer). There were significant differences in MLR and TNF-α at various stages of CKD (p0.05). There was a significant association between MLR (p0.05). In conclusion, MLR is better for assessing the progression of chronic kidney disease compared to NLR and TNF-α.

Key words: Chronic kidney disease, Inflammation, Monocyte to lymphocyte ratio, Neutrophil to lymphocyte ratio, Tumor necrosis factor alpha, Urine Albumin-to-Creatinine Ratio.







Bibliomed Article Statistics

23
26
27
26
27
33
30
15
28
35
19
7
R
E
A
D
S

15

23

14

13

11

9

10

13

10

24

33

8
D
O
W
N
L
O
A
D
S
010203040506070809101112
2025

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.